Inside The Recent Surge In Cancer Biotech IPOs

By Chelsea Naso (July 15, 2015, 8:38 PM EDT) -- ProNAI Therapeutics Inc. raked in $138 million in an initial public offering that hit sweetened terms Wednesday, marking the latest cancer-focused life science company to draw strong demand as the success of previous debuts and the potential for collaborations or acquisitions continues to fuel new listings....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!